Budget Amount *help |
¥21,060,000 (Direct Cost: ¥16,200,000、Indirect Cost: ¥4,860,000)
Fiscal Year 2017: ¥5,330,000 (Direct Cost: ¥4,100,000、Indirect Cost: ¥1,230,000)
Fiscal Year 2016: ¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2015: ¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000)
Fiscal Year 2014: ¥5,850,000 (Direct Cost: ¥4,500,000、Indirect Cost: ¥1,350,000)
|
Outline of Final Research Achievements |
In this study, we have obtained those results, 1) centrally active angiotensin-converting enzyme (ACE) inhibitor, widely used to treat high blood pressure,improved memory function of rat, 2) centrally active ACE inhibitor induced highly expressed peptide in rat brain, 3) diabetic Goto-Kakizaki (GK) rats could be a nice animal model for chronic cardiovascular disease related to diabetic neuropathy, 4)encapsulation of insulin into dipalmitoyl phosphatidylcholine (DPPC) liposomes was more effective for pulmonary insulin absorption than co-administration of DPPC liposomes and unencapsulated free insulin.
|